pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 14·1 min read
save

Ebola outbreak in eastern Congo accelerates, 80% of new cases from unknown transmission chains

Jul 14, 2026·read at STAT ↗Negative

WHO emergencies chief Chikwe Ihekweazu said the Ebola outbreak in eastern Congo is outpacing response efforts, noting that many recent deaths occurred in communities without reaching health facilities.

The outbreak, caused by the rare Bundibugyo virus, began in May and is now the fastest-growing Ebola event on the continent, with at least 1,926 infections and 702 deaths reported across three provinces, and cases also identified in neighboring Uganda.

No approved treatment or vaccine exists, and the U.S. CDC confirmed a U.S. humanitarian worker testing positive, underscoring the risk to responders.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Majority of new Ebola cases in eastern Congo are from unknown chains, as outbreak outpaces response”

read at STAT ↗
540 words · retrieved Jul 14
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.3LILLYTEVA PHARMACEUTICAL INDUSTRIES LTD
drugs
Immunologynicotinenicotine ER
topics
Rare Disease3Vaccine2ImmunologyInfectious Disease

related stories

  • 6h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 1Opinion: What should hospitals do when patients demand unvaccinated donor blood?STAT
  • Dec 23Fierce Biotech Layoff Tracker 2026: Novartis nixes Swiss site; TScan telegraphs 75% headcount dropFierce Biotech
  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech